SCHEMBL252066

SCHEMBL252066

C=CC[SiH](c1ccccc1)C1CCCCO1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL630590 0.80 SLC6A3 (0.34) MGLL
SCHEMBL15301989 0.80 SMN1; SMN2 (0.32) MGLL
SCHEMBL11767953 0.80 SLC6A3 (0.34) MGLL
SCHEMBL9618287 0.78 TDP1 (0.33) MGLL
SCHEMBL2023258 0.78 SLC6A3 (0.33)
SCHEMBL1931237 0.77 SMN1; SMN2 (0.32)
SCHEMBL29005638 0.75 GAA (0.32)
SCHEMBL36086 0.74 SLC6A3 (0.36)
SCHEMBL9813029 0.74 TACR1 (0.30)
SCHEMBL35819 0.74 SMN1; SMN2 (0.36) MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220010169-A1 CURABLE COATING COMPOSITIONS, METHODS, AND ARTICLES 3M INNOVATIVE PROPERTIES COMPANY 2022-01-13 US disclosed
WO-2020109920-A1 CURABLE COATING COMPOSITIONS, METHODS, AND ARTICLES 3M INNOVATIVE PROPERTIES COMPANY (US) 2020-06-04 WO disclosed
US-20190352543-A1 COMPOSITE COMPOSITIONS FOR ELECTROMAGNETIC INTERFERENCE SHIELDING AND ARTICLES INCLUDING THE SAME 3M INNOVATIVE PROPERTIES COMPANY 2019-11-21 US disclosed
EP-3303451-B1 SUPER ACIDS AND BASES AS DEHYDROCONDENSATION CATALYSTS MOMENTIVE PERFORMANCE MAT INC (US) 2019-08-21 EP disclosed
US-10370499-B2 Curable organosiloxane oligomer compositions 3M INNOVATIVE PROPERTIES COMPANY (US) 2019-08-06 US disclosed
US-10364382-B2 Curable polysiloxane compositions and pressure sensitive adhesives made therefrom 3M INNOVATIVE PROPERTIES COMPANY (US) 2019-07-30 US disclosed
WO-2018150297-A1 COMPOSITE COMPOSITIONS FOR ELECTROMAGNETIC INTERFERENCE SHIELDING AND ARTICLES INCLUDING THE SAME 3M INNOVATIVE PROPERTIES COMPANY (US) 2018-08-23 WO disclosed
US-9901912-B2 Super acids and bases as dehydrocondensation catalysts MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2018-02-27 US disclosed
US-20160354769-A1 SUPER ACIDS AND BASES AS DEHYDROCONDENSATION CATALYSTS MOMENTIVE PERFORMANCE MATERIALS INC. 2016-12-08 US disclosed
EP-3090008-A1 CURABLE ORGANOSILOXANE OLIGOMER COMPOSITIONS 3M Innovative Properties Company (US) 2016-11-09 EP disclosed
WO-2013106193-A1 CURABLE POLYSILOXANE COMPOSITION 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-07-18 WO disclosed
WO-2013101535-A1 CURABLE POLYSILOXANE COMPOSITIONS AND PRESSURE SENSITIVE ADHESIVES MADE THEREFROM 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-07-04 WO disclosed
WO-2013101477-A1 CURABLE POLYSILOXANE COATING COMPOSITION 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-07-04 WO disclosed
WO-2013101742-A1 CURABLE-ON-DEMAND POLYSILOXANE COATING COMPOSITION 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-07-04 WO disclosed
EP-2588550-A1 CURABLE POLYSILOXANE COATING COMPOSITION 3M Innovative Properties Company (US) 2013-05-08 EP disclosed
EP-2588536-A1 CURABLE-ON-DEMAND POLYSILOXANE COATING COMPOSITION 3M Innovative Properties Company (US) 2013-05-08 EP disclosed
US-20130101841-A1 CURABLE-ON-DEMAND POLYSILOXANE COATING COMPOSITION 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-04-25 US disclosed
US-20130101840-A1 CURABLE POLYSILOXANE COATING COMPOSITION 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-04-25 US disclosed
WO-2012003108-A1 CURABLE POLYSILOXANE COATING COMPOSITION 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-01-05 WO disclosed
WO-2012003153-A1 CURABLE-ON-DEMAND POLYSILOXANE COATING COMPOSITION 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160354769-A1 SUPER ACIDS AND BASES AS DEHYDROCONDENSATION CATALYSTS STS, DHPS, FDFT1 MGLL 2903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.